Marfan syndrome (MFS) is a relatively common and often lethal disease of connective tissue. Medical, surgical and basic research advances over the last two decades have had a major positive impact on the clinical management of MFS patients. Life expectancy has increased signifi cantly, more discriminating diagnostic criteria have been developed, a number of new clinical entities have been recognized, and exciting opportunities for drug-based therapy have emerged. Despite such a remarkable progress, MFS diagnosis remains diffi cult and aortic disease progression is very het- erogeneous and clinical outcome is unpredictable. Ongoing research efforts are therefore exploiting animal models of MFS to identify novel diagnostic and prognostic biomarkers, genetic, epigenetic and environ- mental modifi ers and druggable biological targets. Keywords
CITATION STYLE
Halper, J. (2014). Progress in Heritable Soft Connective Tissue Diseases. Advances in Experimental Medicine and Biology, 77–94.
Mendeley helps you to discover research relevant for your work.